Conference abstract
Conference abstractPublished 7 Sep 2018
The therapeutic effects of matrine for MCD-induced NASH are associated with upregulation of HSP72 and suppression of mTOR
RMIT University, Australia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Non-alcoholic steatohepatitis (NASH) is an advanced stage of the metabolic syndrome in liver with serious consequences largely because of hepatic injury, inflammation and fibrosis. Matrine (MW: 248) is used as a prescribed hepatoprotective drug in humans and it has been shown by us to decrease hepatosteatosis and glucose intolerance in high fat-fed mice (Bri J Pharmacol 172:4303,2015). Here, we investigated whether matrine exerts therapeutic efficacy for NASH by attenuating hepatic injury, inflammation and fibrosis. The study was performed in methionine choline-deficient (MCD) diet-fed mice for 6 weeks with or without the treatment with matrine (100 mg/kg/d). Compared with untreated MCD-fed mice, matrine markedly reduced hepatic injury (indicated by ALT level, p<0.05), inflammation (indicated by TNFα, CD68 and inflammasome NLRP3, all p<0.05). Along with these effects, matrine inhibited MCD-induced increases in fibrogenesis (as indicated by the expression levels of TGFβ, Smad3 and type I collagen (all p<0.05). Further examination revealed that matrine resecured MCD-suppressed heat shock protein 72 (HSP72, a protective chaperon protein against cell toxicity) and inhibited MCD-activated mTOR (a key master regulator triggering pathogenic pathways leading to NASH). Our findings indicate that matrine attenuated MCD-induced NASH by a new mechanism involving the upregulation of HSP72 and inhibition of mTOR. This hepatoprotective drug may be repurposed for the treatment of NASH.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract
Matrine as a new treatment for hepatosteatosis by suppressing ER stress-associated de novo lipogenesis
Conference abstract · 13 Jul 2015
Auraptene, a major compound of supercritical fluid extract of Phalsak (Citrus hassaku Hort ex Tanaka), induces apoptosis through the suppression of mTOR pathways in human gastric cancer SNU-1 cells
Research article · 19 Dec 2013
RXR agonists inhibit high glucose-induced upregulation of inflammation by suppressing activation of the NADPH oxidase-nuclear factor-κB pathway in human endothelial cells
Conference abstract · 21 Sep 2015
Over-expression of cofilin-1 suppressed growth and invasion of cancer cells is associated with upregulation of let-7 microRNA
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- BylineArticles whose byline prints “Ali Mahzari”
